204 related articles for article (PubMed ID: 32648245)
41. Mesenchymal Stromal Cells and their EVs as Potential Leads for SARSCoV2 Treatment.
Kia V; Eshaghi-Gorji R; Mansour RN; Hassannia H; Hasanzadeh E; Gheibi M; Mellati A; Enderami SE
Curr Stem Cell Res Ther; 2023; 18(1):35-53. PubMed ID: 35473518
[TBL] [Abstract][Full Text] [Related]
42. Mesenchymal stem cells in SARS-CoV-2 infection: A hype or hope.
Pal D; Goyal J; Sharma U; Sharma A; Prashar S; Rathi G; Sharma B; Kumar U
Life Sci; 2021 Nov; 284():119901. PubMed ID: 34453941
[TBL] [Abstract][Full Text] [Related]
43. Elucidating the Pivotal Role of Immune Players in the Management of COVID-19: Focus on Mesenchymal Stem Cells and Inflammation.
Richard SA; Kampo S; Sackey M; Hechavarria ME; Buunaaim ADB; Kuugbee ED; Anabah TW
Curr Stem Cell Res Ther; 2021; 16(2):189-198. PubMed ID: 32628591
[TBL] [Abstract][Full Text] [Related]
44. 2019 novel Coronavirus: current knowledge, cardiovascular implications and management.
Cappannoli L; Scacciavillani R; Iannaccone G; Anastasia G; DI Giusto F; Crea F
Minerva Cardiol Angiol; 2021 Aug; 69(4):377-388. PubMed ID: 32472991
[TBL] [Abstract][Full Text] [Related]
45. Critical roles of cytokine storm and bacterial infection in patients with COVID-19: therapeutic potential of mesenchymal stem cells.
Arjmand B; Alavi-Moghadam S; Sarvari M; Rezaei-Tavirani M; Rezazadeh-Mafi A; Arjmand R; Nikandish M; Nasli-Esfahani E; Larijani B
Inflammopharmacology; 2023 Feb; 31(1):171-206. PubMed ID: 36600055
[TBL] [Abstract][Full Text] [Related]
46. Addressing the Importance of Stem Cell-Based Therapy: A Perspective in the Treatment of COVID-19.
Ibrahim C; Semaan H; El-Sabban M; Najjar F; Hamade A
Curr Mol Med; 2021; 21(6):441-456. PubMed ID: 33208076
[TBL] [Abstract][Full Text] [Related]
47. The role of mesenchymal stem cells in COVID-19 treatment.
Yıldız Gülhan P
Tuberk Toraks; 2020 Dec; 68(4):430-436. PubMed ID: 33448740
[TBL] [Abstract][Full Text] [Related]
48. Therapeutic and Protective Potential of Mesenchymal Stem Cells, Pharmaceutical Agents and Current Vaccines Against COVID-19.
Rasouli M; Vakilian F; Ranjbari J
Curr Stem Cell Res Ther; 2022; 17(2):166-185. PubMed ID: 34530719
[TBL] [Abstract][Full Text] [Related]
49. 'Primed' Mesenchymal Stem Cells: a Potential Novel Therapeutic for COVID19 Patients.
Raza SS; Seth P; Khan MA
Stem Cell Rev Rep; 2021 Feb; 17(1):153-162. PubMed ID: 32592163
[TBL] [Abstract][Full Text] [Related]
50. The Immunomodulatory Role of Cell-Free Approaches in SARS-CoV-2-Induced Cytokine Storm-A Powerful Therapeutic Tool for COVID-19 Patients.
Csobonyeiova M; Smolinska V; Harsanyi S; Ivantysyn M; Klein M
Biomedicines; 2023 Jun; 11(6):. PubMed ID: 37371831
[TBL] [Abstract][Full Text] [Related]
51. Examining the significance of ethics during Covid-19: Overview of the proceedings of the 8th National Bioethics Conference, 2020.
Gangopadhyay J; Davis JC; Kalkoti S; Khadeejath F; Ratha S
Indian J Med Ethics; 2021; VI(4):334-338. PubMed ID: 34666969
[TBL] [Abstract][Full Text] [Related]
52. Tissue repair strategies: What we have learned from COVID-19 in the application of MSCs therapy.
Li YE; Ajoolabady A; Dhanasekaran M; Ren J
Pharmacol Res; 2022 Aug; 182():106334. PubMed ID: 35779816
[TBL] [Abstract][Full Text] [Related]
53. The Doctor's Dilemma: lessons from GB Shaw in a modern pandemic COVID-19.
Molloy EJ
Pediatr Res; 2021 Feb; 89(3):701-703. PubMed ID: 32344425
[TBL] [Abstract][Full Text] [Related]
54. SEVERE CORONAVIRUS DISEASE 2019: FROM PATHOGENESIS TO THERAPY.
Cavaillon JM; Artigas A; Barratt-Due A; Giamarellos-Bourboulis EJ; Gómez H; Hayem G; Vlaar APJ; Wiersinga WJ
Shock; 2023 Mar; 59(3S Suppl 1):10-15. PubMed ID: 36469709
[TBL] [Abstract][Full Text] [Related]
55. Bargain with the tooth fairy - The savings accounts for dental stem cells.
Häfner SJ
Biomed J; 2020 Apr; 43(2):99-106. PubMed ID: 32333995
[TBL] [Abstract][Full Text] [Related]
56. Placenta-derived mesenchymal stem cells (P-MSCs) for COVID-19 pneumonia-a regenerative dogma.
Siddesh SE; Gowda DM; Jain R; Gulati A; Patil GS; Anudeep TC; Jeyaraman N; Muthu S; Jeyaraman M
Stem Cell Investig; 2021; 8():3. PubMed ID: 33688491
[TBL] [Abstract][Full Text] [Related]
57. Taming of Covid-19: potential and emerging application of mesenchymal stem cells.
Najafi-Ghalehlou N; Roudkenar MH; Langerodi HZ; Roushandeh AM
Cytotechnology; 2021 Apr; 73(2):253-298. PubMed ID: 33776206
[TBL] [Abstract][Full Text] [Related]
58. Is There an Effect of Fetal Mesenchymal Stem Cells in the Mother-Fetus Dyad in COVID-19 Pregnancies and Vertical Transmission?
Samara A; Herlenius E
Front Physiol; 2020; 11():624625. PubMed ID: 33679426
[TBL] [Abstract][Full Text] [Related]
59. Mesenchymal stem cells and management of COVID-19 pneumonia.
Metcalfe SM
Med Drug Discov; 2020 Mar; 5():100019. PubMed ID: 32296777
[TBL] [Abstract][Full Text] [Related]
60. SARS-CoV-2: the "Uncensored" Truth about Its Origin and Adipose-Derived Mesenchymal Stem Cells as New Potential Immune-Modulatory Weapon.
Gentile P
Aging Dis; 2021 Apr; 12(2):330-344. PubMed ID: 33815867
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
